October 2018 - Volume 29 - Issue 9
pp: 821-928

Extravasation accidents with liposomal/liposomal pegylated anthracyclines treated with dexrazoxane: an overview and outcomes

Caballero Romero, Álvaro; Delgado Ureña, María Teresa; Salmerón García, Antonio; More

Anti-Cancer Drugs. 29(9):821-826, October 2018.


Dual compartmental targeting of cell cycle and angiogenic kinases in colorectal cancer models

Capasso, Anna; Pitts, Todd M.; Klauck, Peter J.; More

Anti-Cancer Drugs. 29(9):827-838, October 2018.



A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor

Mollica, Veronica; Di Nunno, Vincenzo; Corcioni, Beniamino; More

Anti-Cancer Drugs. 29(9):911-913, October 2018.

Good tolerability of maintenance temozolomide in glioblastoma patients after severe hematological toxicity during concomitant radiotherapy and temozolomide treatment: report of two cases

Lombardi, Giuseppe; Caccese, Mario; Bellu, Luisa; More

Anti-Cancer Drugs. 29(9):924-928, October 2018.